助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   在膀胱癌 在 泌尿科学 分类中 的翻译结果: 查询用时:0.651秒
图标索引 在分类学科中查询
所有学科
泌尿科学
肿瘤学
生物学
妇产科学
心血管系统疾病
更多类别查询

图标索引 历史查询
 

在膀胱癌
相关语句
  in bladder
    Expression of Human Telomerase Reverse Transcriptase Gene (hTERT) in Bladder Cancer and Reversal of the Malignant Phenotype of Bladder Cancer Cell Line T24 by the Antisense Gene Therapy Targeted Against Telomerase
    端粒酶逆转录酶基因hTERT在膀胱癌组织中的表达及端粒酶反义基因治疗逆转T24膀胱癌细胞恶性表型的研究
短句来源
    An Experimental Study on Bcl-xl Gene Expression and RNAi in Bladder Carcinoma
    Bcl-xl基因在膀胱癌中表达与RNA干扰的实验研究
短句来源
    Fibronectin (Fn) distribution in bladder cancer and after intravesical BCG therapy
    纤维连接蛋白在膀胱癌中的分布及BCG膀胱灌注后的变化
短句来源
    Expression of mutant P53 gene in bladder carcinoma and adjacent bladder mucosa
    P53突变蛋白在膀胱癌及癌旁组织中的表达
短句来源
    Expression of ras P21 and P53 in bladder cancer
    rasP21和P53在膀胱癌表达的临床意义
短句来源
更多       
  “在膀胱癌”译为未确定词的双语例句
    Role of Cyclooxygenase-2 in the Development and Treatment of Bladder Cancer
    环氧化酶2在膀胱癌发生发展以及治疗中的作用
短句来源
    Nuclear Matrix Protein 22, Cytokeratin 20 and Survivin As Diagnostic and Prognostic Markers for Bladder Tumor
    核基质蛋白22、细胞角质素20和存活素在膀胱癌诊断和复发预测中的价值
短句来源
    Preliminary Study on the Expression of Survivin and the Combination Therapy with It's Antisense Gene and Recombinant Fusion Protein of Bladder Cancer
    Survivin在膀胱癌的表达及其反义基因联合重组融合蛋白治疗膀胱癌的实验研究
短句来源
    Expression of MTS1 in Human Bladder Cancer and Inhibitory Effects of Wild-type MTS1 on Human Bladder Cancer Cell Line
    MTS1在膀胱癌中的表达及野生型MTS1对人膀胱癌细胞系生长抑制作用的研究
短句来源
    Expression and Significance of ras Oncogene Protein p~21 in Transitional Cell Carcinoma of Bladder
    ras癌基因蛋白p~(21)在膀胱癌表达的意义
短句来源
更多       
查询“在膀胱癌”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  in bladder
In this study, we investigated tissue levels of reduced glutathione (GSH) and carnitine as well as thiobarbituric acid reactive substances (TBARS, as a marker of lipid peroxidation) levels in bladder carcinoma and control group of patients.
      
Combined-Modality Treatment and Organ Preservation in Bladder Cancer
      
Pretreatment Proliferation and Local Control in Bladder Cancer after Radiotherapy with or without Concurrent Chemotherapy
      
The clinical significance of flow cytometric deoxyribonucleic acid measurement of deparaffinized specimen in bladder tumor
      
Aneuploid was the most indicative parameter of the recurrence in bladder tumors.
      
更多          


Paraffin-embedded tumor sections from 53 patients with bladder oaneer, and paraffin-embedded bladder mucosa sections from 7 patients with non-neoplastic urologic diseases were taken and stained with SGI-oncpgema 1, a monoclonal antibody against ras oncoprotein P21, and ABO immunohistochemioal procedures. The results were analysed in combination with the histopathologioal grading and slage of the tumors and the outcome of patients. The P21 expression was positive in 32 of the 53 cases (60.4%) with bladder cancer,...

Paraffin-embedded tumor sections from 53 patients with bladder oaneer, and paraffin-embedded bladder mucosa sections from 7 patients with non-neoplastic urologic diseases were taken and stained with SGI-oncpgema 1, a monoclonal antibody against ras oncoprotein P21, and ABO immunohistochemioal procedures. The results were analysed in combination with the histopathologioal grading and slage of the tumors and the outcome of patients. The P21 expression was positive in 32 of the 53 cases (60.4%) with bladder cancer, and negative in all 7 oases with non-neoplastic urologio diseases. We also found that the rates of P21 positive expression decreased with higher tumor grades and stages. Recurrent rates for tumor cases with P21 positive expression was 17.6% and 82 A % for cases with negative P21 expressions. Follow-up analysis revealed that there was a close correlation between the expression of P21 and prognosis. In the 32 patients with P21 positive expression only 3 (9.4%) died of tumor spread and in 21 patients with negative P21 expression 17 (81%) died of tumor spread, indicating that P21 positive expression is a good prognostic parameter for patients with bladder cancer.

本文用癌基因ras产物P_(21)的单克隆抗体SCI-oncogema 1及ABC免疫酶标染色法对53例膀胱癌和7例泌尿系非肿瘤病人的膀胱粘膜石蜡切片进行染色,结合肿瘤的病理学分级和分期以及病人随访结果进行分析,表明弱例膀胱癌中P_(21)阳性者达32例(60.4%),而7例泌尿系非肿瘤病人的膀胱粘膜标本其P_(21)均为阴性。还发现在膀胱癌P_(21)的阳性率随着病理分级和分期的上升而明显下降,P_(21)阳性膀胱癌其复发率为17.6%,而P_(21)阴性膀胱癌的复发率则高达82.4%。经分析还发现P_(21)表达与膀胱癌预后有密切的相关性,32例P_(21)阳性膀胱癌患者中死于肿瘤者仅3例(9.4%),而21例P_(21)阴性膀胱癌患者中死于肿瘤者多达17例(81%)。提示P_(21)阳性可考虑作为膀胱癌预后较好的客观依据之一。

Nucleal morphometric , DNA and AgNoRs quantification in 86 cases of urinary bladder carcinoma were analysed by computer-assisted image analysing system. The histopathological grading was compared with WHO classification. The result verified that all the 3 quantitative analyses are objective and valuable in grading of the bladder carcinoma, being the best for G1 tumors(90. 9%~100%). AgNoRs is the best for prognosis, DNA being the next. Grading with the synergic analysis of the 3 methods raised the coincidence...

Nucleal morphometric , DNA and AgNoRs quantification in 86 cases of urinary bladder carcinoma were analysed by computer-assisted image analysing system. The histopathological grading was compared with WHO classification. The result verified that all the 3 quantitative analyses are objective and valuable in grading of the bladder carcinoma, being the best for G1 tumors(90. 9%~100%). AgNoRs is the best for prognosis, DNA being the next. Grading with the synergic analysis of the 3 methods raised the coincidence to 88.4%.

应用HI-CI真彩色病理图像分析仪对86例移行细胞癌的核形态,DNA量和AgNoRs颗粒进行了定量分析。三种方法分别和综合作分级判别分析。分级结果与WHO分级结果对比并分析他们与预后的关系。结果证明,三种定量方法在膀胱癌分级诊断中都是比较客观而有价值的方法。1级癌的判别效果最好,一致率为90.9%~100%。各种方法分级与WHO一致率以形态定量法较好,为86.0%,AgNoRs为77.9%,DNA为76.7%。对预后估计的价值以AgNoRs法最好,DNA法次之。三种方法综合分级判别可稍提高分级诊断一致率,达88.4%。

The CEA of tumor

用ABC和IGSS法对10例膀胱组织,2例腺性膀胱炎组织,1例膀胱异位嗜铬细胞瘤组织的癌胚抗原进行免疫组化变化的研究,结果表明10例癌组织的染色均为阳性,阳性率为100%。2例腺性膀胱炎和1例异位嗜铬细胞瘤组织为阴性,CEA在阳性染色的膀胱癌组织中的定位主要为胞膜、胞浆混合型。阳性细胞在膀胱癌组织中的分布主要在上皮的表层,检查膀胱组织CEA可以作为膀胱癌诊断和鉴别诊断的一种手段。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关在膀胱癌的内容
在知识搜索中查有关在膀胱癌的内容
在数字搜索中查有关在膀胱癌的内容
在概念知识元中查有关在膀胱癌的内容
在学术趋势中查有关在膀胱癌的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社